Tilray Brands Inc (OQ:TLRY)
Business Focus: Pharmaceuticals
| Sector: Healthcare | Industry: Pharmaceuticals |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 655 Madison Avenue, 19Th Floor NEW YORK NY 10065 |
| Tel: | N/A |
| Website: | https://www.tilray.com |
| IR: | See website |
| Key People | ||
| Irwin D. Simon Chairman of the Board, President, Chief Executive Officer | Carl A. Merton Chief Financial Officer | Roger Savell Chief Administrative Officer |
| Mitchell S. Gendel Global General Counsel, Corporate Secretary | Denise M. Faltischek Chief Strategy Officer, Head - International | |
| Business Overview |
| Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others. |
| Financial Overview |
| For the nine months ended 29 February 2024, Tilray Brands Inc revenues increased 26% to $559.1M. Net loss decreased 84% to $213.2M. Revenues reflect Beverage Alcohol Business segment increase of 100% to $125.4M, Cannabis Business segment increase of 29% to $200.9M, North America segment increase of 42% to $325.7M, EMEA segment increase of 11% to $222.1M. |
| Employees: | 1,600 as of May 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $1,661M as of Feb 29, 2024 |
| Annual revenue (TTM): | $743.25M as of Feb 29, 2024 |
| EBITDA (TTM): | $202.70M as of Feb 29, 2024 |
| Net annual income (TTM): | -$351.95M as of Feb 29, 2024 |
| Free cash flow (TTM): | -$49.96M as of Feb 29, 2024 |
| Net Debt Last Fiscal Year: | $236.84M as of Feb 29, 2024 |
| Shares outstanding: | 774,028,558 as of Apr 5, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.